Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials-Reference-Cited by-全球学者库

Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials

Published:2017-01-15 Issue:12 Volume:8 Page:20410-20417
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Baoxing¹,Bo Yacong²,Wang Kunlun¹,Liu Yang¹,Tang Xiance¹,Zhao Yan¹,Zhao Erjiang¹,Yuan Ling¹

Affiliation:

1. Affiliated Tumor Hospital of Zhengzhou University, Henan Tumor Hospital, Zhengzhou, Henan, China

2. Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Affiliated Tumor Hospital of Zhengzhou University, Henan Tumor Hospital, Zhengzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant radiochemotherapy with cisplatin/5-flourouracil or carboplatin/paclitaxel in patients with resectable cancer of the esophagus and the gastroesophageal junction — comparison of postoperative mortality and complications, toxicity, and pathological tumor response;Langenbeck's Archives of Surgery;2023-11-08

2. Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction;Journal of Surgical Oncology;2022-09-21

3. Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma;Biomedicines;2022-08-04

4. Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma;Cancer Biotherapy and Radiopharmaceuticals;2021-09-15

5. Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma;Experimental and Therapeutic Medicine;2021-05-03